Balance Sheet Data
Vascular Biogenics Ltd. (VBLT)
$0.215
+0.00 (+0.47%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 50.48 | 36.54 | 30.29 | 53.15 | 17.67 | 39.56 | 42.44 | 45.52 | 48.84 | 52.39 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.52 | 0.63 | 0.32 | 0.47 | 0.49 | 0.52 | 0.56 | 0.60 | 0.65 | 0.69 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.19 | 3.33 | 1.96 | 4.33 | 2.59 | 2.78 | 2.98 | 3.19 | 3.43 | 3.68 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.23 | -0.07 | -0.05 | -1.47 | -0.81 | -1.01 | -1.08 | -1.16 | -1.24 | -1.33 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.